Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 14, 2007
Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudinePatrick Marcellin, Olivier Lada, Tarik AsselahLa Revue Du Praticien|April 2, 2011
[Treatment of chronic hepatitis B]Tarik Asselah, Olivier Lada, Patrick MarcellinJournal of Virology|February 28, 2006
Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variantsOlivier Lada, Yves Benhamou, Thierry Poynard, et al.Expert Opinion on Investigational Drugs|November 18, 2008
Clevudine: a promising therapy for the treatment of chronic hepatitis BTarik Asselah, Olivier Lada, Rami Moucari, et al.Antiviral Therapy|July 21, 2004
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovirOlivier Lada, Yves Benhamou, Annie Cahour, et al.Clinics in Liver Disease|November 6, 2007
Interferon therapy for chronic hepatitis BTarik Asselah, Olivier Lada, Rami Moucari, et al.Psychiatry Research|June 23, 2024
Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims databaseBenjamin Rolland, Nabil Hallouche, Olivier Lada, et al.The Lancet Regional Health. Europe|December 24, 2021
Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS)Stanislas Pol, Fayssoil Fouad, Magali Lemaitre, et al.Antimicrobial Agents and Chemotherapy|April 28, 2005
Clinically relevant genotype interpretation of resistance to didanosineAnne-Geneviève Marcelin, Philippe Flandre, Juliette Pavie, et al.Antiviral Therapy|July 26, 2005
Comparison of tests and procedures to build clinically relevant genotypic scores: application to the Jaguar studyPhilippe Flandre, Anne-Geneviève Marcelin, Juliette Pavie, et al.Pageof 3